Results 1 - 20 of 119 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Web Resources
|
|
Benzinga: Myokardia Analysts See Mavacamten As Blockbuster Opportunity For Bristol-Myers SquibbNewstex Finance & Accounting Blogs, 2020Copyright Newstex Oct 6, 2020Digital Resources/Online E-Resources |
| 2 |
Material Type: Web Resources
|
|
Proactive Investors: BridgeBio Pharma stock soars on heart disease drug study resultsNewstex Finance & Accounting Blogs, 2023Copyright Newstex Jul 17, 2023Digital Resources/Online E-Resources |
| 3 |
Material Type: Web Resources
|
|
CardiomyopathySmart Engage. Diseases & Conditions, 20201997-2020 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.Digital Resources/Online E-Resources |
| 4 |
Material Type: Web Resources
|
|
Cardiotoxicity associated with immune checkpoint inhibitors: A retrospective analysis of patients at an academic tertiary care centerResearch Square, 20202020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.21203/rs.3.rs-50662/v3Digital Resources/Online E-Resources |
| 5 |
Material Type: Web Resources
|
|
Zacks Investment Research: Cytokinetics (CYTK) Up 83% as Cardiomyopathy Drug Meets GoalsNewstex Finance & Accounting Blogs, 2023Copyright Newstex Dec 28, 2023Digital Resources/Online E-Resources |
| 6 |
Material Type: Web Resources
|
|
PharmaTimes: Scientists to rewrite DNA in search for heart disease curePharmaTimes, 2022Copyright Newstex Jul 28, 2022Digital Resources/Online E-Resources |
| 7 |
Material Type: Web Resources
|
|
Proactive Investors: Cardiol Therapeutics wins FDA approval for clinical trial of CardiolRx to treat patients with acute myocarditisNewstex Finance & Accounting Blogs, 2021Copyright Newstex Aug 24, 2021Digital Resources/Online E-Resources |
| 8 |
Material Type: Web Resources
|
|
Proactive Investors: Cardiol Therapeutics wins FDA approval for clinical trial of CardiolRx to treat patients with acute myocarditisNewstex Finance & Accounting Blogs, 2021Copyright Newstex Aug 24, 2021Digital Resources/Online E-Resources |
| 9 |
Material Type: Web Resources
|
|
MedicalResearch.com - Eminent Domains, Inc.: First-in-Class Drug Mavacamten Reduces LVH Associated with Heart Failure and AFibMedicalResearch.com [BLOG], 2020Copyright Newstex Nov 19, 2020Digital Resources/Online E-Resources |
| 10 |
Material Type: Web Resources
|
|
Zolmax.com - American Consumer News: Reviewing Tenaya Therapeutics (NASDAQ:TNYA) and Kiromic BioPharma (NASDAQ:KRBP)Newstex Global Business Blogs, 2024Copyright Newstex Mar 17, 2024Digital Resources/Online E-Resources |
| 11 |
Material Type: Web Resources
|
|
Newsfile Corp.: Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre FoundationNewstex Finance & Accounting Blogs, 2023Copyright Newstex Jan 19, 2023Digital Resources/Online E-Resources |
| 12 |
Material Type: Web Resources
|
|
Zolmax.com - American Consumer News: Head-To-Head Analysis: Tenaya Therapeutics (NASDAQ:TNYA) and Sorrento Therapeutics (NASDAQ:SRNE)Newstex Global Business Blogs, 2024Copyright Newstex Feb 27, 2024Digital Resources/Online E-Resources |
| 13 |
Material Type: Web Resources
|
|
24/7 Wall St.: Why MyoKardia’s Late-Stage Hypertophric Cardiomyopathy Study Is a Big HitNewstex Finance & Accounting Blogs, 2020Copyright Newstex May 11, 2020Digital Resources/Online E-Resources |
| 14 |
Material Type: Web Resources
|
|
American Banking and Market News - American Consumer News: Critical Review: Tenaya Therapeutics (NASDAQ:TNYA) versus Genenta Science (NASDAQ:GNTA)Newstex Finance & Accounting Blogs, 2023Copyright Newstex Nov 24, 2023Digital Resources/Online E-Resources |
| 15 |
Material Type: Web Resources
|
|
Newsfile Corp.: Hemostemix Announces the Appointment of Dr. Nadia Giannetti, MD, to its Scientific Advisory BoardNewstex Finance & Accounting Blogs, 2022Copyright Newstex Sep 16, 2022Digital Resources/Online E-Resources |
| 16 |
Material Type: Web Resources
|
|
Newsfile Corp.: Hemostemix Announces the Appointment of Dr. Renzo Cecere, MD, FRCSC to Its Scientific Advisory BoardNewstex Finance & Accounting Blogs, 2022Copyright Newstex Sep 14, 2022Digital Resources/Online E-Resources |
| 17 |
Material Type: Web Resources
|
|
Newsfile Corp.: Hemostemix Announces A ClarificationNewstex Finance & Accounting Blogs, 2022Copyright Newstex Aug 31, 2022Digital Resources/Online E-Resources |
| 18 |
Material Type: Web Resources
|
|
Watchlist News - American Consumer News: Head to Head Survey: Aceragen (NASDAQ:ACGN) vs. Tenaya Therapeutics (NASDAQ:TNYA)Newstex Finance & Accounting Blogs, 2023Copyright Newstex Sep 26, 2023Digital Resources/Online E-Resources |
| 19 |
Material Type: Web Resources
|
|
Ticker Report - American Consumer News: Financial Contrast: Kiromic BioPharma (NASDAQ:KRBP) versus Tenaya Therapeutics (NASDAQ:TNYA)Newstex Finance & Accounting Blogs, 2024Copyright Newstex Mar 10, 2024Digital Resources/Online E-Resources |
| 20 |
Material Type: Web Resources
|
|
American Banking and Market News - American Consumer News: Analyzing Sorrento Therapeutics (NASDAQ:SRNE) & Tenaya Therapeutics (NASDAQ:TNYA)Newstex Finance & Accounting Blogs, 2024Copyright Newstex Feb 25, 2024Digital Resources/Online E-Resources |
Results 1 - 20 of 119 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 2015 (2)
- 2015 To 2016 (16)
- 2017 To 2018 (7)
- 2019 To 2021 (27)
- After 2021 (63)
-
More options
New Records
Subject
- Cardiomyopathy (112)
- Earnings Per Share (61)
- Institutional Investments (59)
- Gene Therapy (53)
- Corporate Profits (52)
- Ratings & Rankings (46)
- Valuation (46)
- Stock Prices (45)
- Biotechnology Industry (32)
- Clinical Trials (27)
- Mutation (25)
- Volatility (19)
- Patients (16)
- Cardiovascular Disease (13)
- Transplants & Implants (12)
- Stem Cells (12)
- Biological Products (10)
- Cardiology (10)
- Cancer (9)
-
More options
Databases
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||